Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C025984 |
15-hydroxy-5,8,11,13-eicosatetraenoic acid |
UGT1A4 protein results in increased glucuronidation of 15-hydroxy-5,8,11,13-eicosatetraenoic acid | increases glucuronidation | 15231852
|
C033146 |
1-hydroxypyrene |
UGT1A4 protein results in increased glucuronidation of 1-hydroxypyrene | increases glucuronidation | 15802387
|
C055987 |
20-hydroxy-5,8,11,14-eicosatetraenoic acid |
UGT1A4 protein results in increased glucuronidation of 20-hydroxy-5,8,11,14-eicosatetraenoic acid | increases glucuronidation | 15231852
|
C060533 |
2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine |
UGT1A4 protein results in increased glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine | increases glucuronidation | 15310245
|
C006757 |
4-biphenylamine |
UGT1A4 protein results in increased glucuronidation of 4-biphenylamine | increases glucuronidation | 15840509
|
C016583 |
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
UGT1A4 gene polymorphism results in increased glucuronidation of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | increases glucuronidation | 14871856
|
C016583 |
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
UGT1A4 protein results in increased glucuronidation of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | increases glucuronidation | 14871856
|
C033541 |
afloqualone |
Trifluoperazine inhibits the reaction [UGT1A4 protein results in increased glucuronidation of afloqualone] | decreases reaction|increases glucuronidation | 15475412
|
C033541 |
afloqualone |
UGT1A4 protein results in increased glucuronidation of afloqualone | increases glucuronidation | 15475412
|
D000738 |
Androsterone |
UGT1A4 protein SNP results in increased glucuronidation of Androsterone analog | increases glucuronidation | 15708967
|
D016718 |
Arachidonic Acid |
UGT1A4 protein results in increased glucuronidation of Arachidonic Acid | increases glucuronidation | 15231852
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased activity of UGT1A4 protein | increases activity | 17065433
|
D020111 |
Chlorodiphenyl (54% Chlorine) |
Chlorodiphenyl (54% Chlorine) results in increased expression of UGT1A4 mRNA | increases expression | 17851650
|
D003024 |
Clozapine |
UGT1A4 protein SNP results in increased glucuronidation of Clozapine | increases glucuronidation | 15708967
|
D003367 |
Cotinine |
UGT1A4 protein results in increased glucuronidation of Cotinine | increases glucuronidation | 14570768 16141602
|
D004008 |
Diclofenac |
UGT1A4 protein results in increased glucuronidation of Diclofenac | increases glucuronidation | 15843492
|
D005204 |
Farnesol |
UGT1A4 protein results in increased glucuronidation of Farnesol | increases glucuronidation | 15320866
|
D005480 |
Flurbiprofen |
UGT1A4 protein results in increased glucuronidation of Flurbiprofen | increases glucuronidation | 15843492
|
C001419 |
hydroxyphenytoin |
UGT1A4 protein results in increased glucuronidation of and results in decreased activity of hydroxyphenytoin | decreases activity|increases glucuronidation | 15855726
|
D007099 |
Imipramine |
UGT1A4 protein affects the metabolism of Imipramine | affects metabolic processing | 15286053
|
D007099 |
Imipramine |
UGT1A4 protein results in increased glucuronidation of Imipramine | increases glucuronidation | 14570768 9264550
|
D007099 |
Imipramine |
UGT1A4 protein SNP results in increased glucuronidation of Imipramine | increases glucuronidation | 15708967
|
D007213 |
Indomethacin |
UGT1A4 protein results in increased glucuronidation of Indomethacin | increases glucuronidation | 15843492
|
D007660 |
Ketoprofen |
UGT1A4 protein results in increased glucuronidation of Ketoprofen | increases glucuronidation | 15843492
|
C047781 |
lamotrigine |
[Phenobarbital results in increased activity of UGT1A4 protein] which results in increased glucuronidation of lamotrigine | increases activity|increases glucuronidation | 19845433
|
C047781 |
lamotrigine |
[pirinixic acid results in increased activity of UGT1A4 protein] which results in increased glucuronidation of lamotrigine | increases activity|increases glucuronidation | 19845433
|
C047781 |
lamotrigine |
[Pregnenolone Carbonitrile results in increased activity of UGT1A4 protein] which results in increased glucuronidation of lamotrigine | increases activity|increases glucuronidation | 19845433
|
C047781 |
lamotrigine |
UGT1A4 protein results in increased glucuronidation of lamotrigine | increases glucuronidation | 19845433 17151188
|
D008727 |
Methotrexate |
Methotrexate results in increased expression of UGT1A4 mRNA | increases expression | 20854796
|
D009538 |
Nicotine |
UGT1A4 protein results in increased glucuronidation of Nicotine | increases glucuronidation | 14570768 16141602
|
C010257 |
N'-nitrosoanabasine |
UGT1A4 protein results in increased glucuronidation of N'-nitrosoanabasine | increases glucuronidation | 18238858
|
C032978 |
N'-nitrosoanatabine |
UGT1A4 protein results in increased glucuronidation of N'-nitrosoanatabine | increases glucuronidation | 18238858
|
C008655 |
N'-nitrosonornicotine |
UGT1A4 protein results in increased glucuronidation of N'-nitrosonornicotine | increases glucuronidation | 18238858
|
D010634 |
Phenobarbital |
Phenobarbital results in increased activity of UGT1A4 protein | increases activity | 19845433
|
D010634 |
Phenobarbital |
[Phenobarbital results in increased activity of UGT1A4 protein] which results in increased glucuronidation of lamotrigine | increases activity|increases glucuronidation | 19845433
|
C006253 |
pirinixic acid |
pirinixic acid results in increased activity of UGT1A4 protein | increases activity | 19845433
|
C006253 |
pirinixic acid |
[pirinixic acid results in increased activity of UGT1A4 protein] which results in increased glucuronidation of lamotrigine | increases activity|increases glucuronidation | 19845433
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of UGT1A4 mRNA | increases expression | 17151188
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of UGT1A4 protein | increases expression | 17151188
|
D011285 |
Pregnenolone Carbonitrile |
Pregnenolone Carbonitrile results in increased activity of UGT1A4 protein | increases activity | 16155002 19845433
|
D011285 |
Pregnenolone Carbonitrile |
[Pregnenolone Carbonitrile results in increased activity of UGT1A4 protein] which results in increased glucuronidation of lamotrigine | increases activity|increases glucuronidation | 19845433
|
D011285 |
Pregnenolone Carbonitrile |
Pregnenolone Carbonitrile results in increased expression of UGT1A4 mRNA | increases expression | 16155002
|
D011285 |
Pregnenolone Carbonitrile |
Pregnenolone Carbonitrile results in increased expression of UGT1A4 protein | increases expression | 16155002
|
D000644 |
Quaternary Ammonium Compounds |
UGT1A4 protein results in increased glucuronidation of Quaternary Ammonium Compounds | increases glucuronidation | 9264550
|
C046297 |
sarsasapogenin |
UGT1A4 protein SNP results in decreased glucuronidation of sarsasapogenin | decreases glucuronidation | 15708967
|
D013467 |
Sulindac |
UGT1A4 protein results in increased glucuronidation of Sulindac | increases glucuronidation | 15843492
|
C025463 |
sulindac sulfone |
UGT1A4 protein results in increased glucuronidation of sulindac sulfone | increases glucuronidation | 15843492
|
C115070 |
SX 3030 |
UGT1A4 protein results in increased glucuronidation of SX 3030 | increases glucuronidation | 15013842
|
C115070 |
SX 3030 |
UGT1A4 protein results in increased glycosylation of SX 3030 | increases glycosylation | 15013842
|
D013629 |
Tamoxifen |
UGT1A4 protein results in increased glucuronidation of Tamoxifen | increases glucuronidation | 15135306
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased activity of UGT1A4 protein | increases activity | 16155002
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of UGT1A4 mRNA | increases expression | 16155002 18433817
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of UGT1A4 protein | increases expression | 16155002
|
D013749 |
Tetrachlorodibenzodioxin |
UGT1A4 promoter SNP affects the susceptibility to Tetrachlorodibenzodioxin | affects response to substance | 18433817
|
D014268 |
Trifluoperazine |
Trifluoperazine inhibits the reaction [UGT1A4 protein results in increased glucuronidation of afloqualone] | decreases reaction|increases glucuronidation | 15475412
|
D014268 |
Trifluoperazine |
UGT1A4 protein results in increased glucuronidation of Trifluoperazine | increases glucuronidation | 15135306 15475412
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Sulindac |
11.73 | 14745880 |
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
11.73 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
12.10 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
12.10 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
12.10 | 11752688 14514962 15322242 |
MESH:D058186 |
Acute Kidney Injury |
|
Diclofenac |
8.28 | 7897758 |
MESH:D058186 |
Acute Kidney Injury |
|
Sulindac |
8.28 | 7897758 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.77 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
6.63 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Indomethacin |
6.63 | 16537180 |
MESH:D000230 |
Adenocarcinoma |
|
Sulindac |
6.63 | 11910360 |
MESH:D000236 |
Adenoma |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
14.23 | 16176798 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
14.23 | 6695378 |
MESH:D000236 |
Adenoma |
|
Indomethacin |
14.23 | 11497255 |
MESH:D000236 |
Adenoma |
|
Sulindac |
14.23 | 10223192 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
15.08 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
15.08 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
15.08 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Flurbiprofen |
14.64 | 10680582 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Sulindac |
14.64 | 11874996 11535846 16460482 19003578 17611924 15623613 12394442 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
sulindac sulfone |
14.64 | 16150858 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.68 | 16160616 12649775 14617031 |
MESH:D016301 |
Alveolar Bone Loss |
|
Indomethacin |
4.98 | 17225004 |
MESH:D000544 |
Alzheimer Disease |
|
Indomethacin |
4.41 | 17627676 15579461 |
MESH:D000544 |
Alzheimer Disease |
|
Nicotine |
4.41 | 16627626 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.62 | 11748828 |
MESH:D001014 |
Aortic Aneurysm |
|
Indomethacin |
4.49 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
10.47 | 19183758 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Indomethacin |
10.47 | 10388637 |
MESH:D018771 |
Arthralgia |
|
Indomethacin |
4.78 | 2160914 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Indomethacin |
4.73 | 11248219 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
4.73 | 17286800 |
MESH:D001321 |
Autistic Disorder |
|
Arachidonic Acid |
3.07 | 18582451 |
MESH:D001477 |
Bartter Syndrome |
|
Indomethacin |
4.61 | 10684365 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
7.64 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.64 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.40 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.52 | 15746008 |
MESH:D001913 |
Bowen's Disease |
|
Sulindac |
4.97 | 11207687 |
MESH:D001929 |
Brain Edema |
|
Indomethacin |
4.64 | 11481608 |
MESH:D002545 |
Brain Ischemia |
|
Indomethacin |
4.04 | 12524144 |
MESH:D001943 |
Breast Neoplasms |
|
4-biphenylamine |
4.38 | 17671175 |
MESH:D001943 |
Breast Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
4.38 | 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
4.38 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Indomethacin |
4.38 | 17401462 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
4.38 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Sulindac |
4.38 | 16642371 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
4.38 | 17261762 18855134 19189210 18629630 19115204 19155303 16873071 20005174 15565566 18815881 21152245 19011961 20390343 19066611 19487384 20859285 19410462 18351453 21138602 16273361 19288272 18821012 20544844 20135344 19200415 17242785 19189212 16818667 17049068 19103187 17440819 20065188 19289846 19221464 15668708 18997820 17893378 18425577 19059307 19142967 11161223 19084267 18984771 16202921 19244106 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.38 | 20435547 |
MESH:D002056 |
Burns |
|
Indomethacin |
4.33 | 10459503 |
MESH:D002100 |
Cachexia |
|
Indomethacin |
4.62 | 11239499 15141370 15625704 16537180 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.50 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.13 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Indomethacin |
4.29 | 16391822 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
4.29 | 1701930 20935162 6705139 20007298 17173139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
4.29 | 16924424 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Indomethacin |
4.35 | 11053908 |
MESH:D018276 |
Carcinoma, Medullary |
|
Indomethacin |
4.97 | 14736730 18791128 11352223 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfone |
3.95 | 18758305 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Indomethacin |
3.19 | 17341418 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.37 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Indomethacin |
4.37 | 12636206 15482327 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.29 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.15 | 16120746 18670907 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4-biphenylamine |
4.49 | 15746073 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.88 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.84 | 16835633 |
MESH:D002764 |
Cholecystitis |
|
Indomethacin |
4.78 | 11181007 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.55 | 19176532 |
MESH:D043171 |
Chromosomal Instability |
|
4-biphenylamine |
6.62 | 17671175 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.94 | 16354765 15340226 12621046 8697196 15668235 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
4.59 | 17123785 |
MESH:D003110 |
Colonic Neoplasms |
|
Indomethacin |
3.95 | 11260862 15936596 15637740 15786552 15963497 15625704 |
MESH:D003110 |
Colonic Neoplasms |
|
Sulindac |
3.95 | 12458338 12902858 |
MESH:D015179 |
Colorectal Neoplasms |
|
4-biphenylamine |
4.66 | 17671175 |
MESH:D015179 |
Colorectal Neoplasms |
|
Indomethacin |
4.66 | 12606626 17054584 18059344 11197048 |
MESH:D015179 |
Colorectal Neoplasms |
|
Sulindac |
4.66 | 11076880 18059344 11197048 10666051 |
MESH:D015179 |
Colorectal Neoplasms |
|
sulindac sulfone |
4.66 | 18059344 11197048 10666051 10416599 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.74 | 17141729 14669216 |
MESH:D018352 |
Coronavirus Infections |
|
Indomethacin |
5.33 | 17302372 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
2.62 | 9562676 12039119 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.62 | 10048152 20055451 15322242 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
3.91 | 19747007 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.99 | 19031437 |
MESH:D003866 |
Depressive Disorder |
|
Imipramine |
4.51 | 20305041 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.24 | 18249437 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
4.76 | 20191521 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
4.16 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.16 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.16 | 19279558 |
MESH:D003930 |
Diabetic Retinopathy |
|
Sulindac |
4.82 | 12861449 17621415 |
MESH:D003967 |
Diarrhea |
|
Indomethacin |
3.44 | 7237001 7907874 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.17 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
3.66 | 17851650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.66 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.48 | 11462148 |
MESH:D004374 |
Ductus Arteriosus, Patent |
|
Indomethacin |
4.77 | 18446180 12774134 18043480 16326151 17190690 16133044 |
MESH:D004381 |
Duodenal Ulcer |
|
Indomethacin |
3.78 | 17151854 17202747 17351913 11595431 17329845 11595415 11535926 11991626 17045617 10671773 16699067 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
3.91 | 16402076 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.65 | 1851702 |
MESH:D020821 |
Dystonic Disorders |
|
Nicotine |
5.54 | 17881519 |
MESH:D004487 |
Edema |
|
Arachidonic Acid |
27.44 | 9831321 9599246 16716910 11698051 15177302 7990266 |
MESH:D004487 |
Edema |
|
Diclofenac |
27.44 | 16273134 |
MESH:D004487 |
Edema |
|
Imipramine |
27.44 | 12798668 |
MESH:D004487 |
Edema |
|
Indomethacin |
27.44 | 19703484 7990266 7907874 10653021 8985016 16100529 8273558 |
MESH:D004487 |
Edema |
|
Ketoprofen |
27.44 | 7990266 |
MESH:D004487 |
Edema |
|
pirinixic acid |
27.44 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
27.44 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.51 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
3.18 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
2.80 | 19155303 17893378 16202921 20544844 |
MESH:D004715 |
Endometriosis |
|
Indomethacin |
13.49 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Sulindac |
13.49 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
13.49 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Indomethacin |
4.12 | 18509659 |
MESH:D004751 |
Enteritis |
|
Indomethacin |
4.36 | 17763956 10567023 16328016 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
Indomethacin |
4.61 | 17980183 |
MESH:D004802 |
Eosinophilia |
|
Indomethacin |
3.69 | 11298111 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
lamotrigine |
5.79 | 20235791 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
lamotrigine |
10.27 | 17275665 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
10.27 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
lamotrigine |
9.40 | 17116037 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
9.40 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
lamotrigine |
6.71 | 19668019 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
6.71 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.23 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
3.88 | 7750514 |
MESH:D004833 |
Epilepsy, Temporal Lobe |
|
lamotrigine |
6.45 | 16499746 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.64 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
6.77 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Indomethacin |
6.77 | 11005569 |
MESH:D004938 |
Esophageal Neoplasms |
|
Sulindac |
6.77 | 12235107 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.73 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
6.55 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
6.55 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.00 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.08 | 11858732 |
MESH:D005334 |
Fever |
|
Arachidonic Acid |
8.50 | 11852909 |
MESH:D005334 |
Fever |
|
Indomethacin |
8.50 | 17627676 10431976 11852909 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Sulindac |
11.68 | 14745880 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
11.68 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Sulindac |
10.37 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
10.37 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Indomethacin |
4.51 | 10962813 |
MESH:D005355 |
Fibrosis |
|
Indomethacin |
7.59 | 17994277 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.59 | 20067830 |
MESH:D005499 |
Folliculitis |
|
Indomethacin |
4.78 | 11298111 |
MESH:D005756 |
Gastritis |
|
Indomethacin |
4.36 | 15046732 |
MESH:D005764 |
Gastroesophageal Reflux |
|
Sulindac |
4.65 | 11910360 |
MESH:D005909 |
Glioblastoma |
|
Indomethacin |
3.32 | 12870263 |
MESH:D005910 |
Glioma |
|
Indomethacin |
3.07 | 18371953 16487511 |
MESH:D005923 |
Glomerulosclerosis, Focal Segmental |
|
Indomethacin |
3.98 | 11849393 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.21 | 10696789 |
MESH:D006073 |
Gout |
|
Indomethacin |
4.97 | 11248219 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
4.78 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Indomethacin |
3.49 | 15482327 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
5.76 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.76 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.30 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.00 | 11000095 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Indomethacin |
4.23 | 15633222 |
MESH:D019698 |
Hepatitis C, Chronic |
|
Indomethacin |
4.32 | 15135802 |
MESH:D006521 |
Hepatitis, Chronic |
|
Diclofenac |
5.29 | 14986274 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
12.23 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
12.23 | 19772884 18467677 19176532 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
12.23 | 16120746 12621046 15340226 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.66 | 15340226 8697196 18606429 16354765 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Indomethacin |
3.48 | 12727271 |
MESH:D034321 |
Hyperamylasemia |
|
Indomethacin |
5.33 | 17883296 |
MESH:D006940 |
Hyperemia |
|
Indomethacin |
4.62 | 12524144 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.85 | 20558911 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
4.53 | 16046005 |
MESH:D006949 |
Hyperlipidemias |
|
Indomethacin |
3.81 | 17546600 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.76 | 18670907 18850075 |
MESH:D007077 |
Ileal Diseases |
|
Indomethacin |
4.64 | 18306037 10574470 |
MESH:D007079 |
Ileitis |
|
Indomethacin |
4.97 | 16133968 10647630 10651667 |
MESH:D007235 |
Infant, Premature, Diseases |
|
Indomethacin |
4.98 | 16133044 |
MESH:D007249 |
Inflammation |
|
Arachidonic Acid |
25.06 | 9831321 15177302 17371808 |
MESH:D007249 |
Inflammation |
|
Diclofenac |
25.06 | 16273134 |
MESH:D007249 |
Inflammation |
|
Flurbiprofen |
25.06 | 11099482 |
MESH:D007249 |
Inflammation |
|
Imipramine |
25.06 | 12798668 |
MESH:D007249 |
Inflammation |
|
Indomethacin |
25.06 | 12568917 3291741 7812673 |
MESH:D007249 |
Inflammation |
|
Sulindac |
25.06 | 3291741 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
25.06 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
25.06 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.38 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Indomethacin |
3.95 | 10210152 17329856 15610444 11686837 17994277 15831440 11855677 11713966 18236018 |
MESH:D007414 |
Intestinal Neoplasms |
|
Sulindac |
4.31 | 12663524 12628509 12584176 10223192 12351151 10213222 |
MESH:D007417 |
Intestinal Polyps |
|
Sulindac |
4.64 | 12394442 11245490 |
MESH:D019586 |
Intracranial Hypertension |
|
Indomethacin |
4.98 | 15241188 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.00 | 16580747 |
MESH:D007579 |
Jejunal Diseases |
|
Indomethacin |
4.64 | 16133968 18306037 10574470 |
MESH:D007674 |
Kidney Diseases |
|
Indomethacin |
3.05 | 17190690 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
2.74 | 18625569 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
4.75 | 9562676 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Indomethacin |
3.60 | 11703811 10320625 12228301 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Indomethacin |
3.64 | 15631656 16572323 10785260 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Indomethacin |
2.57 | 18360721 |
MESH:D007964 |
Leukocytosis |
|
Indomethacin |
4.98 | 16537180 |
MESH:D007969 |
Leukomalacia, Periventricular |
|
Indomethacin |
5.33 | 17980183 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
11.83 | 17567588 |
MESH:D008064 |
Lipidoses |
|
Imipramine |
11.83 | 17567588 15342952 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
11.83 | 15342952 17567588 |
MESH:D008101 |
Liver Abscess, Amebic |
|
Indomethacin |
5.33 | 11479899 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
6.25 | 14986274 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
6.25 | 21047994 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
Sulindac |
3.98 | 12468960 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Indomethacin |
4.51 | 18194892 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.51 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
4.51 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.51 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Diclofenac |
6.23 | 14566034 16867024 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
6.23 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
Sulindac |
6.23 | 16867024 14986274 |
MESH:D008113 |
Liver Neoplasms |
|
4-biphenylamine |
19.52 | 15761837 |
MESH:D008113 |
Liver Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
19.52 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
19.52 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
19.52 | 19482888 15975961 19073162 8742319 21047994 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
19.52 | 15890375 16377806 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
19.52 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
19.52 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4-biphenylamine |
8.67 | 11376689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
8.67 | 6150874 1399818 2563599 17172636 18308698 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
8.67 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
4.63 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
4-biphenylamine |
9.86 | 17671175 |
MESH:D008175 |
Lung Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
9.86 | 14755239 16401635 16061637 12438228 18508827 15172992 9255578 17139156 18813816 19931552 15893417 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
9.86 | 20064080 18520028 6695378 17053015 20135361 20464547 20869020 18816296 18569708 |
MESH:D008175 |
Lung Neoplasms |
|
Indomethacin |
9.86 | 16537180 11497255 11053908 |
MESH:D008175 |
Lung Neoplasms |
|
Sulindac |
9.86 | 19359593 15713900 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
9.86 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
9.86 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
3.68 | 17352296 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.38 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.39 | 14580682 19196723 11731420 19196722 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.16 | 19453300 |
MESH:D008545 |
Melanoma |
|
Sulindac |
3.37 | 16642371 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.37 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.80 | 15990972 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
7.40 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Imipramine |
7.40 | 16856516 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.10 | 19142101 |
MESH:D008708 |
Methemoglobinemia |
|
4-biphenylamine |
5.06 | 12030840 |
MESH:D008881 |
Migraine Disorders |
|
Indomethacin |
3.40 | 11903285 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
7.69 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Indomethacin |
7.69 | 12636206 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
4.90 | 17488658 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.14 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
1.98 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.72 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.66 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.09 | 17484760 |
MESH:D009362 |
Neoplasm Metastasis |
|
Indomethacin |
5.41 | 16537180 11053908 11239499 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.41 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.39 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
7.21 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Nicotine |
7.21 | 16365874 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
7.21 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
Indomethacin |
3.77 | 10663608 15625704 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.61 | 19196722 19189210 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Nicotine |
4.61 | 16365874 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
2.85 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Indomethacin |
7.89 | 12349958 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Sulindac |
7.89 | 16850258 17266991 |
MESH:D009765 |
Obesity |
|
Clozapine |
4.35 | 19142110 18515891 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.35 | 20558911 |
MESH:D007752 |
Obstetric Labor, Premature |
|
Indomethacin |
4.78 | 6374098 |
MESH:D010003 |
Osteoarthritis |
|
Diclofenac |
7.44 | 18287210 |
MESH:D010003 |
Osteoarthritis |
|
Indomethacin |
7.44 | 7009135 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
3.98 | 17016548 |
MESH:D010146 |
Pain |
|
Diclofenac |
13.81 | 13679232 |
MESH:D010146 |
Pain |
|
Imipramine |
13.81 | 12798668 |
MESH:D010146 |
Pain |
|
Indomethacin |
13.81 | 13679232 3291741 17440234 17627676 |
MESH:D010146 |
Pain |
|
Sulindac |
13.81 | 3291741 |
MESH:D010149 |
Pain, Postoperative |
|
Indomethacin |
4.29 | 12538197 18702446 |
MESH:D010190 |
Pancreatic Neoplasms |
|
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone |
8.00 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
8.00 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Sulindac |
8.00 | 11504793 16820089 |
MESH:D010195 |
Pancreatitis |
|
Indomethacin |
3.58 | 17883296 15028970 |
MESH:D010257 |
Paraneoplastic Syndromes |
|
Indomethacin |
5.33 | 16537180 |
MESH:D020734 |
Parkinsonian Disorders |
|
Indomethacin |
3.79 | 12349958 |
MESH:D051302 |
Paroxysmal Hemicrania |
|
Indomethacin |
5.33 | 11903285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.86 | 12520081 |
MESH:D010437 |
Peptic Ulcer |
|
Indomethacin |
4.77 | 11148446 |
MESH:D010518 |
Periodontitis |
|
Indomethacin |
4.53 | 17225004 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.20 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
3.30 | 2563599 |
MESH:D047928 |
Premature Birth |
|
Indomethacin |
4.75 | 17000239 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.81 | 11896295 11118676 11399792 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.28 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Flurbiprofen |
2.28 | 17409433 |
MESH:D011471 |
Prostatic Neoplasms |
|
sulindac sulfone |
2.28 | 15570007 17908994 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.28 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Indomethacin |
3.81 | 11849393 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.11 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.30 | 17410198 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
3.91 | 15331141 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.34 | 17352296 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.20 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.47 | 18990726 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
2.68 | 17123785 16141801 20521326 17667964 17726453 20168265 20452607 18855531 20521320 19369910 20107430 20580759 11151749 11763009 18806925 |
MESH:D012640 |
Seizures |
|
lamotrigine |
8.77 | 9844417 16499746 |
MESH:D012640 |
Seizures |
|
Nicotine |
8.77 | 17873105 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
8.77 | 3137016 16876388 4039156 11442880 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.44 | 6407741 |
OMIM:608579 |
SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO |
|
lamotrigine |
6.22 | 20485159 19668019 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
4.85 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
4.85 | 16192470 |
MESH:D012892 |
Sleep Deprivation |
|
Imipramine |
5.81 | 19798453 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
3.90 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.66 | 19457130 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
lamotrigine |
5.73 | 20235791 |
MESH:D013272 |
Stomach Diseases |
|
Indomethacin |
4.04 | 10486359 15038085 18209964 18545984 10192188 17638125 10215738 16280098 16184426 16113693 15472012 17207306 17160473 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.47 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Indomethacin |
3.47 | 15609394 |
MESH:D013274 |
Stomach Neoplasms |
|
N'-nitrosonornicotine |
3.47 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
Indomethacin |
3.26 | 17135157 1323529 14567935 18193104 12787963 17657623 17627676 16631530 18209962 17895592 18087811 10878458 15138204 16934674 11595415 11906479 12500499 10423059 18181030 17977527 16169175 11595431 11145282 17918041 12498302 18431645 16252198 12077510 18543354 16150113 17654042 18726076 15255614 10750652 11523592 18299717 11729361 15104355 18237397 16755016 16397915 12467913 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
4.67 | 9562676 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.51 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Indomethacin |
6.45 | 14736730 11352223 18791128 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
6.45 | 1399818 |
OMIM:188890 |
TOBACCO ADDICTION, SUSCEPTIBILITY TO |
|
Nicotine |
4.45 | 16720336 16785264 11259349 |
MESH:D014029 |
Tobacco Use Disorder |
|
Nicotine |
5.08 | 18041664 15735609 18305452 17979512 |
MESH:D014456 |
Ulcer |
|
Indomethacin |
4.51 | 17380554 10574470 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4-biphenylamine |
7.61 | 12376482 6654951 11144890 17671175 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
7.61 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
7.61 | 17572228 8653321 16712894 |
MESH:D014594 |
Uterine Neoplasms |
|
Sulindac |
4.24 | 18645019 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.21 | 12125929 |
MESH:D014839 |
Vomiting |
|
Indomethacin |
4.36 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.86 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
4.15 | 16402076 16141801 20107430 20521320 20564506 17502770 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
4.70 | 17933447 |